When it was first described in the nineteenth century, cutaneous T-cell lymphoma looked like a fungus infection of the skin with large, mushroom-like protuberances, so it was called "mycosis fungoides." In the 1980s, research by Yale School of Medicine’s Dr. Richard Edelson, Chairman of the Department of Dermatology, proved that the disease was caused by a malignancy of the lymphocytes, and he renamed it cutaneous T-cell lymphoma (CTCL).
CTCL is currently a central research interest of the Department of Dermatology and the focus of a well-organized interdisciplinary group of scientists and clinicians at the Yale Cancer Center. Our researchers are currently exploring the uses of new technologies to treat cutaneous T-cell lymphoma and other diseases, including graft versus host disease.
Visit yalestudies.org to view available clinical trials or learn more about clinical research at Yale.